Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab.This case report depicts how a case of the subretinal neovascular membrane was managed with intravitreal ranibizumab injections.  The patient was treated for the wet ARMD with intravitreal injections of 0.5 mg ranibizumab administered one month apart in the right eye. 
Ranibizumab
Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab.This case report depicts how a case of the subretinal neovascular membrane was managed with intravitreal ranibizumab injections.  The patient was treated for the wet ARMD with intravitreal injections of 0.5 mg ranibizumab administered one month apart in the right eye. 
Ranibizumab
Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab.This case report depicts how a case of the subretinal neovascular membrane was managed with intravitreal ranibizumab injections.  The patient was treated for the wet ARMD with intravitreal injections of 0.5 mg ranibizumab administered one month apart in the right eye. 
Ranibizumab